Fractyl Health (GUTS) Total Liabilities (2023 - 2026)
Fractyl Health (GUTS) reported Total Liabilities of $78.0 million for Q1 2026, up 1.75% year-on-year from $76.7 million in Q1 2025, and down 30.32% quarter-over-quarter from $111.9 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Total Liabilities data on file, last reported at $78.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 1.75% year-over-year to $78.0 million; the trailing twelve-month figure through Mar 2026 stood at $78.0 million (up 1.75% YoY), and the FY2025 full-year result was $111.9 million, up 40.54% from the prior year.
- Total Liabilities for Q1 2026 stood at $78.0 million, down from $111.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $307.2 million in Q3 2023 and bottomed at $75.7 million in Q2 2024.
- A 4-year average of $134.8 million and a median of $80.2 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 75.06% in 2024 and soared 53.32% in 2025, its largest moves.
- Tracing GUTS's Total Liabilities over 4 years: stood at $113.9 million in 2023, then tumbled by 30.09% to $79.7 million in 2024, then soared by 40.54% to $111.9 million in 2025, then tumbled by 30.32% to $78.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $78.0 million, $111.9 million, and $117.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 9.45 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 10.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 78.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.01 Mn |
| Dec 31, 2025 | 111.94 Mn |
| Sep 30, 2025 | 117.45 Mn |
| Jun 30, 2025 | 80.22 Mn |
| Mar 31, 2025 | 76.67 Mn |
| Dec 31, 2024 | 79.65 Mn |
| Sep 30, 2024 | 76.60 Mn |
| Jun 30, 2024 | 75.68 Mn |
| Mar 31, 2024 | 79.34 Mn |
| Dec 31, 2023 | 113.94 Mn |
| Sep 30, 2023 | 307.18 Mn |
| Jun 30, 2023 | 292.52 Mn |
| Mar 31, 2023 | 263.39 Mn |